[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eyepoint Inc (EYPT)

Eyepoint Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eyepoint Inc 480 PLEASANT STREET WATERTOWN MA 02472 USA

www.eyepointpharma.com Employees: 214 P: 617-926-5000 F: 617-926-5050

Sector:

Medical

Description:

EYEPOINT INC is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. EYEPOINT INC, formerly known as EyePoint Pharmaceuticals Inc., is based in WATERTOWN, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,205,634
Enterprise Value, $K 1,103,814
Shares Outstanding, K 83,841
Float, K 79,540
% Float 94.87%
Short Interest, K 15,098
Short Float 18.01%
Days to Cover 15.09
Short Volume Ratio 0.65
% of Insider Shareholders 5.13%
% of Institutional Shareholders 99.41%

Financials:

Annual Sales, $ 31,370 K
Annual Net Income, $ -231,960 K
Last Quarter Sales, $ 700 K
Last Quarter Net Income, $ -84,830 K
EBIT, $ -281,840 K
EBITDA, $ -284,360 K

Growth:

1-Year Return 56.86%
3-Year Return 65.52%
5-Year Return 63.27%
5-Year Revenue Growth -8.91%
5-Year Earnings Growth 8.65%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.99 on 05/06/26
Next Earnings Date 08/05/26
Earnings Per Share ttm -3.50
EPS Growth vs. Prev Qtr -22.22%
EPS Growth vs. Prev Year -52.31%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/09/20

EYPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -110.54%
Return-on-Assets % -90.15%
Profit Margin % -739.43%
Debt/Equity 0.00
Price/Sales 36.69
Price/Cash Flow N/A
Price/Book 4.99
Book Value/Share 2.75
Interest Coverage -7,721.67
60-Month Beta 1.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.